Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair disease research is a growing and evolving field in dermatology, with recent significant advances.

Combining modern and Unani treatments may offer better care for hirsutism in PCOS.

Phytoconstituents from Cyperus Rotundus may help treat hirsutism by interacting with the 5 α reductase enzyme.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

New treatments for male hypogonadism are effective and should be personalized.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Minoxidil use increases facial hair growth in females, more in older users.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Certain drugs change freshwater snail shells to a "banana" shape.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.